Responsible, safe, and effective prescription of opioids for chronic non-cancer pain

American society of interventional pain physicians (ASIPP) guidelines

Laxmaiah Manchikanti, Adam M. Kaye, Nebojsa Nick Knezevic, Heath McAnally, Andrea M. Trescot, Susan Blank, Vidyasagar Pampati, Salahadin Abdi, Jay S. Grider, Alan D. Kaye, Kavita N. Manchikanti, Harold J. Cordner, Christopher G. Gharibo, Michael E. Harned, Sheri L. Albers, Sairam Atluri, Steve M. Aydin, Sanjay Bakshi, Robert Barkin, Ramsin M. Benyamin & 28 others Mark V. Boswell, Ricardo M. Buenaventura, Aaron K. Calodney, David L. Cedeno, Sukdeb Datta, Timothy R. Deer, Bert Fellows, Vincent Galan, Vahid Grami, Hans Hansen, Standiford Helm, Rafael Justiz, Dhanalakshmi Koyyalagunta, Yogesh Malla, Annu Navani, Kent Nouri, Ramarao Pasupuleti, Nalini Sehgal, Sanford M. Silverman, Thomas T. Simopoulos, Vijay Singh, Konstantin V. Slavin, Daneshvari R. Solanki, Peter S. Staats, Ricardo Vallejo, Bradley W. Wargo, Arthur Watanabe, Joshua A. Hirsch

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).

Original languageEnglish (US)
Pages (from-to)S3-S92
JournalPain Physician
Volume20
Issue number2
StatePublished - Feb 1 2017

Fingerprint

Opioid Analgesics
Prescriptions
Guidelines
Physicians
Pain
Conflict of Interest
Public Opinion
Health Services Research
Methadone
Heroin
Disclosure
Fentanyl
Substance-Related Disorders
Quality of Life
Organizations

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Manchikanti, L., Kaye, A. M., Knezevic, N. N., McAnally, H., Trescot, A. M., Blank, S., ... Hirsch, J. A. (2017). Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines. Pain Physician, 20(2), S3-S92.

Responsible, safe, and effective prescription of opioids for chronic non-cancer pain : American society of interventional pain physicians (ASIPP) guidelines. / Manchikanti, Laxmaiah; Kaye, Adam M.; Knezevic, Nebojsa Nick; McAnally, Heath; Trescot, Andrea M.; Blank, Susan; Pampati, Vidyasagar; Abdi, Salahadin; Grider, Jay S.; Kaye, Alan D.; Manchikanti, Kavita N.; Cordner, Harold J.; Gharibo, Christopher G.; Harned, Michael E.; Albers, Sheri L.; Atluri, Sairam; Aydin, Steve M.; Bakshi, Sanjay; Barkin, Robert; Benyamin, Ramsin M.; Boswell, Mark V.; Buenaventura, Ricardo M.; Calodney, Aaron K.; Cedeno, David L.; Datta, Sukdeb; Deer, Timothy R.; Fellows, Bert; Galan, Vincent; Grami, Vahid; Hansen, Hans; Helm, Standiford; Justiz, Rafael; Koyyalagunta, Dhanalakshmi; Malla, Yogesh; Navani, Annu; Nouri, Kent; Pasupuleti, Ramarao; Sehgal, Nalini; Silverman, Sanford M.; Simopoulos, Thomas T.; Singh, Vijay; Slavin, Konstantin V.; Solanki, Daneshvari R.; Staats, Peter S.; Vallejo, Ricardo; Wargo, Bradley W.; Watanabe, Arthur; Hirsch, Joshua A.

In: Pain Physician, Vol. 20, No. 2, 01.02.2017, p. S3-S92.

Research output: Contribution to journalArticle

Manchikanti, L, Kaye, AM, Knezevic, NN, McAnally, H, Trescot, AM, Blank, S, Pampati, V, Abdi, S, Grider, JS, Kaye, AD, Manchikanti, KN, Cordner, HJ, Gharibo, CG, Harned, ME, Albers, SL, Atluri, S, Aydin, SM, Bakshi, S, Barkin, R, Benyamin, RM, Boswell, MV, Buenaventura, RM, Calodney, AK, Cedeno, DL, Datta, S, Deer, TR, Fellows, B, Galan, V, Grami, V, Hansen, H, Helm, S, Justiz, R, Koyyalagunta, D, Malla, Y, Navani, A, Nouri, K, Pasupuleti, R, Sehgal, N, Silverman, SM, Simopoulos, TT, Singh, V, Slavin, KV, Solanki, DR, Staats, PS, Vallejo, R, Wargo, BW, Watanabe, A & Hirsch, JA 2017, 'Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines', Pain Physician, vol. 20, no. 2, pp. S3-S92.
Manchikanti, Laxmaiah ; Kaye, Adam M. ; Knezevic, Nebojsa Nick ; McAnally, Heath ; Trescot, Andrea M. ; Blank, Susan ; Pampati, Vidyasagar ; Abdi, Salahadin ; Grider, Jay S. ; Kaye, Alan D. ; Manchikanti, Kavita N. ; Cordner, Harold J. ; Gharibo, Christopher G. ; Harned, Michael E. ; Albers, Sheri L. ; Atluri, Sairam ; Aydin, Steve M. ; Bakshi, Sanjay ; Barkin, Robert ; Benyamin, Ramsin M. ; Boswell, Mark V. ; Buenaventura, Ricardo M. ; Calodney, Aaron K. ; Cedeno, David L. ; Datta, Sukdeb ; Deer, Timothy R. ; Fellows, Bert ; Galan, Vincent ; Grami, Vahid ; Hansen, Hans ; Helm, Standiford ; Justiz, Rafael ; Koyyalagunta, Dhanalakshmi ; Malla, Yogesh ; Navani, Annu ; Nouri, Kent ; Pasupuleti, Ramarao ; Sehgal, Nalini ; Silverman, Sanford M. ; Simopoulos, Thomas T. ; Singh, Vijay ; Slavin, Konstantin V. ; Solanki, Daneshvari R. ; Staats, Peter S. ; Vallejo, Ricardo ; Wargo, Bradley W. ; Watanabe, Arthur ; Hirsch, Joshua A. / Responsible, safe, and effective prescription of opioids for chronic non-cancer pain : American society of interventional pain physicians (ASIPP) guidelines. In: Pain Physician. 2017 ; Vol. 20, No. 2. pp. S3-S92.
@article{d0951e8bb2664ac0a35a90191fcb7050,
title = "Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines",
abstract = "Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92{\%}) believe that opioids reduce pain and a smaller proportion (57{\%}) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).",
author = "Laxmaiah Manchikanti and Kaye, {Adam M.} and Knezevic, {Nebojsa Nick} and Heath McAnally and Trescot, {Andrea M.} and Susan Blank and Vidyasagar Pampati and Salahadin Abdi and Grider, {Jay S.} and Kaye, {Alan D.} and Manchikanti, {Kavita N.} and Cordner, {Harold J.} and Gharibo, {Christopher G.} and Harned, {Michael E.} and Albers, {Sheri L.} and Sairam Atluri and Aydin, {Steve M.} and Sanjay Bakshi and Robert Barkin and Benyamin, {Ramsin M.} and Boswell, {Mark V.} and Buenaventura, {Ricardo M.} and Calodney, {Aaron K.} and Cedeno, {David L.} and Sukdeb Datta and Deer, {Timothy R.} and Bert Fellows and Vincent Galan and Vahid Grami and Hans Hansen and Standiford Helm and Rafael Justiz and Dhanalakshmi Koyyalagunta and Yogesh Malla and Annu Navani and Kent Nouri and Ramarao Pasupuleti and Nalini Sehgal and Silverman, {Sanford M.} and Simopoulos, {Thomas T.} and Vijay Singh and Slavin, {Konstantin V.} and Solanki, {Daneshvari R.} and Staats, {Peter S.} and Ricardo Vallejo and Wargo, {Bradley W.} and Arthur Watanabe and Hirsch, {Joshua A.}",
year = "2017",
month = "2",
day = "1",
language = "English (US)",
volume = "20",
pages = "S3--S92",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "2",

}

TY - JOUR

T1 - Responsible, safe, and effective prescription of opioids for chronic non-cancer pain

T2 - American society of interventional pain physicians (ASIPP) guidelines

AU - Manchikanti, Laxmaiah

AU - Kaye, Adam M.

AU - Knezevic, Nebojsa Nick

AU - McAnally, Heath

AU - Trescot, Andrea M.

AU - Blank, Susan

AU - Pampati, Vidyasagar

AU - Abdi, Salahadin

AU - Grider, Jay S.

AU - Kaye, Alan D.

AU - Manchikanti, Kavita N.

AU - Cordner, Harold J.

AU - Gharibo, Christopher G.

AU - Harned, Michael E.

AU - Albers, Sheri L.

AU - Atluri, Sairam

AU - Aydin, Steve M.

AU - Bakshi, Sanjay

AU - Barkin, Robert

AU - Benyamin, Ramsin M.

AU - Boswell, Mark V.

AU - Buenaventura, Ricardo M.

AU - Calodney, Aaron K.

AU - Cedeno, David L.

AU - Datta, Sukdeb

AU - Deer, Timothy R.

AU - Fellows, Bert

AU - Galan, Vincent

AU - Grami, Vahid

AU - Hansen, Hans

AU - Helm, Standiford

AU - Justiz, Rafael

AU - Koyyalagunta, Dhanalakshmi

AU - Malla, Yogesh

AU - Navani, Annu

AU - Nouri, Kent

AU - Pasupuleti, Ramarao

AU - Sehgal, Nalini

AU - Silverman, Sanford M.

AU - Simopoulos, Thomas T.

AU - Singh, Vijay

AU - Slavin, Konstantin V.

AU - Solanki, Daneshvari R.

AU - Staats, Peter S.

AU - Vallejo, Ricardo

AU - Wargo, Bradley W.

AU - Watanabe, Arthur

AU - Hirsch, Joshua A.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).

AB - Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).

UR - http://www.scopus.com/inward/record.url?scp=85016172210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016172210&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - S3-S92

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 2

ER -